TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections.

Clinical trial NCT01170221 · COMPLETED

Trial details

NCT number: NCT01170221
Sponsor: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Skin and Subcutaneous Tissue Bacterial Infections

Start date: 2010-08-15
Primary completion: 2011-09-30
Enrollment: 667

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.